SALES BOOM BUT BLACKMORES LOSES SPEED ON ASX

SALES BOOM BUT BLACKMORES LOSES SPEED ON ASX
BLACKMORES (ASX: BKL) sales climbed 52 per cent in the year to June, resulting in a profit increase in the triple digits.

The Sydney vitamin and supplement maker says growing demand means it doubled production capacity over the year.

Still, with the good news, Blackmores delivered a word of caution about the volatility of the Australian wholesale market, which has 'softened in recent weeks impacted by retailers destocking and some exporters changing the channels through which they acquire products'.

Blackmores expects its first quarter result to be down - and investors weren't impressed, with the company shedding more than 12 per cent within 90 minutes after opening.

Sales for the most recent reporting period totalled $717 million, which the company extracted a net profit after tax of $100 million from.

Blackmores' Australian business delivered $494 million of these sales, while its Pure Animal Wellbeing (PAW) animal health division grew 31 per cent to achieve $7 million in sales.

Blackmores CEO Christine Holgate (pictured) says Asia delivered mixed results, on the whole experiencing a strong sales year, but Korea having a few challenges.

"The region delivered top line growth achieving sales of $81 million (up 6 per cent) including sales from Thailand and Malaysia," says Holgate.

"Asia sales were bolstered by in-country sales in China of $48 million (up 536 per cent). The expansion of free trade zones and our ability to serve e-commerce customers through our bonded warehouse in China have enabled us to benefit from the opportunities in Asia.

"We estimate that Chinese consumers influence over $250 million of our group sales through a combination of export sales, in-country sales and sales through Australian retailers."

Blackmores will be launching in Indonesia next month hoping to capitalise on a fast growing middle class and growing health consciousness.

In the US, Blackmores intends to spread its business where it has just commenced distribution for BioCeuticals, a practitioner-only range acquired in 2012 showing 25 per cent year-on-year growth.

Blackmores will pay a final dividend of $2.10 per share, taking the total yearly dividend to $4.10, up 102 per cent on last year. Shareholders will be paid on September 21.

Blackmores is trading at around $142 on the ASX this morning.

Read about Blackmores' record first half result earlier this year which exceeded its FY15 profit.

Get our daily business news

Sign up to our free email news updates.

Please tick to verify that you are not a robot

 
Coraggio: the ‘life-changing’ impact of a unique business community
Partner Content
Richard Skarzynski has been a private business owner for the past 40 years, building a ...
Coraggio
Advertisement

Related Stories

HMC Capital secures $650m in commitments to finalise Healthscope hospital acquisitions

HMC Capital secures $650m in commitments to finalise Healthscope hospital acquisitions

HMC Capital (ASX: HMC) has secured $650 million in commitments from...

ARA forecasts $490m Halloween treat for retailers

ARA forecasts $490m Halloween treat for retailers

Australians are expected to spend 14 per cent more on Halloween fes...

Sydney proptech Archistar gets picked up for pilot program in Texas

Sydney proptech Archistar gets picked up for pilot program in Texas

A Sydney-based technology platform that uses artificial intelligenc...

Costa board accepts $1.4b takeover offer from Paine Schwartz, Driscoll’s and BCI

Costa board accepts $1.4b takeover offer from Paine Schwartz, Driscoll’s and BCI

One of Australia’s largest fruit and vegetable producers, Cos...